You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 302 No. 15, October 21, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Men's Health
 •Men's Health, Other
 •Oncology
 •Colon Cancer
 •Surgery
 •Surgical Interventions
 •Colorectal Surgery
 •Women's Health
 •Women's Health, Other
 •Gastroenterology
 •Gastrointestinal Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Differences in Colon Adenomas and Carcinomas Among Women and Men

Potential Clinical Implications

Hemant K. Roy, MD; Laura K. Bianchi, MD

JAMA. 2009;302(15):1696-1697.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Colorectal cancer remains the third leading cause of cancer deaths among women and men in the United States, underscoring the need for more effective preventive strategies for both sexes. Many promising approaches are based on the adenoma-carcinoma paradigm of colon carcinogenesis. The clinical corollary to this model is that the presence of adenomas represents a robust marker of colon carcinogenesis. This leads to 2 distinct applications for colorectal cancer prevention: target for intervention and risk marker. Indeed, removing adenomas through colonoscopy has been shown to decrease future colorectal cancer occurrence by 75% to 90%. From a screening perspective, the colonoscopic adenoma identification is used clinically to gauge long-term risk and dictate the frequency of future colorectal cancer screening.

Most data suggest that the effect of colorectal cancer is approximately equivalent in both sexes. In 2009, an estimated 71 380 women and 75 590 men . . . [Full Text of this Article]

Author Affiliations: Department of Internal Medicine, NorthShore University HealthSystems, Evanston, Illinois, and University of Chicago Pritzker School of Medicine, Chicago, Illinois.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.